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Abstract: This study evaluates the relation of a Mediterranean dietary pattern and its individual
components with the cardiovascular risk factors profile, plasma glucose and body mass index
(BMI) in people with type 2 diabetes. We studied 2568 participants at 57 diabetes clinics. Diet was
assessed with the EPIC (European Prospective Investigation into Cancer and Nutrition) questionnaire,
adherence to the Mediterranean diet was evaluated with the relative Mediterranean diet score (rMED).
A high compared to a low score was associated with a better quality of diet and a greater adherence
to the nutritional recommendations for diabetes. However, even in the group achieving a high
score, only a small proportion of participants met the recommendations for fiber and saturated
fat (respectively 17% and 30%). Nonetheless, a high score was associated with lower values of
plasma lipids, blood pressure, glycated hemoglobin, and BMI. The relationship of the single food
items components of the rMED score with the achievement of treatment targets for plasma lipids,
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blood pressure, glucose, and BMI were also explored. The study findings support the Mediterranean
dietary model as a suitable model for type 2 diabetes and the concept that the beneficial health effects
of the Mediterranean diet lie primarily in its synergy among various nutrients and foods rather than
on any individual component.
Keywords: Mediterranean diet; diabetes; cardiovascular risk; glucose control; plasma lipids; relative
Mediterranean diet score
1. Introduction
Diet remains the cornerstone of effective type 2 diabetes management; the aim of promoting
nutritional changes in people with diabetes is to optimize metabolic control and overall health.
Nutritional recommendations have been issued by several scientific societies to support clinicians in the
choice of the most suitable dietary intervention(s) in people with diabetes [1]. However, adherence to
these recommendations in real life clinical practice is generally poor [2–4] and partly reflects the wider
problem of the overabundance of saturated fat and refined cereals in the western diet [5]. Furthermore,
nutritional recommendations are based on nutrients, which might hamper patients’ understanding
and compliance. Last but not least, nutritional recommendations have been criticized as being scarcely
based on evidence, and there is debate in the literature regarding the optimal dietary macronutrient
composition of the diet in people with type 2 diabetes under energy balanced conditions [1,6,7].
In the last decades, human nutrition science has shifted from a reductionist approach focused on
specific nutrients to a broader view emphasizing the concepts of overall dietary quality and patterns
that promote metabolic health [8]. This paradigm change is supported by convincing evidence that food
exposure is complex and its impact on health is influenced not only by single nutrients, but also by their
interplay and by the interactions of the bioactive non-nutrients present in food (i.e., fiber, antioxidants,
minerals, etc.). Therefore, the relationship between nutrition and health may not be fully appreciated
unless evaluated within the context of the whole diet.
The Mediterranean diet is among the most widely studied dietary patterns. The traditional
Mediterranean diet is characterized by the consumption of whole grains, legumes, fruits, vegetables,
nuts, fish and olive oil, wine in moderation, and a moderate intake of meat, dairy products, processed
foods and sweets. The Mediterranean dietary pattern is also an important source of vitamins, minerals,
antioxidants, mono- and poly-unsaturated fatty acids, and fiber—all of which provide a wide range
of health benefits. There is abundant evidence of its health benefits [9–12]; in addition, this type
of diet has also a great potential for long-term adherence and sustainability [13]. However, data in
populations with diabetes are scant; available information is mostly restricted to the experimental
setting of controlled trials whereas little is known on the impact of a Mediterranean like dietary pattern
on metabolic outcomes in real life clinical practice [14,15]. Furthermore, Mediterranean diet is a broad
term used to describe the traditional food choices of people living around the Mediterranean basin,
but there is remarkably little information on the protective/detrimental health impact of specific food
groups. In particular, it is unclear whether the beneficial health effects of the Mediterranean diet are
due to the diet as a whole or are driven by key food/food components that could also be provided
as supplements.
Against this background, the aims of the study were to analyze the food and nutrient intake
of a large cohort of people with type 2 diabetes in real-life clinical practice, to explore the impact of
a Mediterranean-like dietary pattern on major cardiovascular risk factors, glucose control and body
weight, and identify whether and to what extent the beneficial effect of the Mediterranean diet are
driven by some food items/components which may be particularly beneficial for people with type
2 diabetes.
Nutrients 2018, 10, 1067 3 of 12
2. Materials and Methods
2.1. Study Population
To explore the study questions, we used data collected within the framework of the TOSCA.IT
study—a randomized controlled trial (NCT00700856) designed to compare the effects of a sulfonylurea
or pioglitazone, in add-on to metformin, on cardiovascular events in people with type 2 diabetes
inadequately controlled with metformin monotherapy. Details on inclusion and exclusion criteria
are reported elsewhere [16,17]. Briefly men and women with type 2 diabetes, aged 50–75 years,
with glycated hemoglobin 7.0–9.0%, were recruited in 57 centers distributed throughout Italy. People
with impaired renal function (serum creatinine ≥ 1.5 mg/dL), a cardiovascular event in the previous
six months, and conditions other than diabetes requiring special dietary treatment were excluded from
the study. The study protocol was approved by the Ethics Review Board of the Coordinating Center
and of each participating center, and written informed consent was obtained from all participants
before entering the study. For the purposes of this study, only baseline data, collected prior to the
randomization to the study treatments, were used. The present analyses include 2568 men and women
with a complete data set.
2.2. Measurements
Body weight, height, waist and hip circumference were measured with standard procedures,
body mass index (BMI) was calculated as weight (kg)/height (m2). Sitting blood pressure was
measured according to a standard protocol. Blood samples were obtained in the morning after
an overnight fast, all biochemical analyses were performed in a central laboratory. Total and HDL
cholesterol, triglycerides and high sensitivity C-reactive protein (CRP) were measured by standard
methods. LDL cholesterol was calculated according to the Friedewald equation only for triglyceride
values <400 mg/dL. Glycated hemoglobin (HbA1c) was measured with high liquid performance
chromatography standardized according to IFCC.
2.3. Evaluation of Eating Habits
Eating habits were assessed with the European Prospective Investigation into Cancer and
Nutrition (EPIC) questionnaire, a validated method frequently used in large epidemiological
studies [18,19]; details have been given elsewhere [3,6]. Briefly, the questionnaire contained 248 items
on 188 different foods including the type of fat used as condiment or added after cooking. People
were asked to indicate the absolute frequency of consumption of each item (per day, week, month or
year), and the quantity of the food consumed by selection of pictures showing a small, medium and
large portion size, with additional quantifiers (e.g., “smaller than the small portion” or “between the
small and medium portion”, etc.). Incomplete questionnaires and questionnaires with implausible
data (i.e., energy intake less than 800 or greater than 5000 kcal/day) were excluded from the analyses.
A specific software (Nutrition Analysis of food frequency questionnaire—FFQ), developed by the
Epidemiology and Prevention Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, was used
to convert dietary data from the questionnaire into average daily amounts of foods (g/day) [18,19].
Nutrition analysis of FFQ was linked to the Italian Food Composition Tables (FCTs) for nutrients and
energy assessment [20,21]. The intake of polyphenols was evaluated using the USDA database [22]
in combination with the Phenol-Explorer®database [23] to enable the examination of the polyphenol
content of as many foods as possible. Details have been given elsewhere [24,25].
2.4. Adherence to the Mediterranean Diet
The adherence to the Mediterranean dietary model was evaluated with the rMED score
(relative Mediterranean diet score), a variation of the original Mediterranean diet score, proposed
by Buckland [26] and based on the intake of 9 key food groups: fruits, vegetables, legumes, cereals,
fish, olive oil, meat and meat products, dairy products, and alcohol. The consumption of each food
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group (except alcohol) was measured as grams per 1000 kcal/day to adjust for energy density and
divided into tertiles. A score of 0, 1, or 2 was assigned to the first, second, or third tertile of intake,
assigning a positive score for high intakes for the 6 food groups fitting the Mediterranean model:
fruit (including nuts and seeds but excluding fruit juices), vegetables (excluding potatoes), legumes,
cereals (including whole-grain and refined flour, pasta, rice, other grains, and bread), fish and seafood,
olive oil. The scoring was reversed for meat (including fresh and processed meat) and dairy products
(including high- and low-fat milk, cheese, cream desserts, and dairy and nondairy creams), assigning
a positive score for lower intakes. Alcohol was scored as a dichotomous variable as in prior studies: two
points were assigned for moderate consumption—defined as 5–25 g/day for women and 10–50 g/day
for men—and 0 points were assigned for a consumption above or below the sex-specific range. For each
participant a total score was calculated by summing the scores obtained for each of the 9 food groups.
Values for the rMED score ranged from 0 to 18; based on this score, three groups with low (score 0–6),
intermediate (score 7–10) or high (score 11–18) were created [26]. The rMED score was selected among
others for this study as it excludes sweetened beverages and potatoes which are foods restricted in
people with diabetes.
2.5. Statistical Analysis
Data are shown as mean and standard deviation (M ± SD) or number and proportions,
as appropriate. The analysis of variance (ANOVA) with linear term and the post-hoc test adjusted
for multiple comparisons (Bonferroni test) were used to test for the differences in the composition
of the habitual diet, blood pressure and metabolic parameters across categories of adherence to the
Mediterranean Diet and between the highest vs. lowest rMED score, respectively. The λ2 test was used
to compare proportions. A binary logistic regression analysis was performed to evaluate the association
of total rMED score and single food groups components of the rMED score with the achievement
of treatment targets for the major cardiovascular risk factors (i.e., LDL cholesterol, triglycerides,
HDL cholesterol, blood pressure), measures of glucose control—glycated hemoglobin—and BMI.
A p-value < 0.05 (two-tailed) was considered statistically significant. All analyses were conducted with
the SPSS Statistics software for Windows (version 20.0; SPSS Inc., Chicago, IL, USA).
3. Results
The study population consists of 1534 males and 1034 females with mean age 62.1 ± 6.5 years
and BMI 30.3 ± 4.4 kg/m2. Table 1 shows the general features of the study participants according
to the rMED score groups. A high adherence score was significantly more frequent among females
(p = 0.002), older people (p = 0.027) and residents of the southern regions (p < 0.0001). No relation was
found with education, smoking, or marital status.
Tables 2 and 3 report the average food consumption and nutrient composition of the diet in the
three rMED score groups. By definition, people with a high adherence score consumed substantially
more fruit, vegetables, legumes, cereals, fish, olive oil, and alcohol, and substantially less meat, and
dairy products (Table 2).
Eating a high rMED diet was characterized by a lower energy content, a lower intake of proteins
from animal food sources, saturated fat and cholesterol, added sugars, a higher intake of fiber and
a lower glycemic index and glycemic load (Table 3). As for micronutrients, a high rMED score was
associated with a significantly lower intake of calcium and sodium and a significantly higher intake of
total polyphenols (Table 3); no significant difference was detected for potassium intake.
We also evaluated the adherence to the current nutritional recommendation for people with
diabetes in the participants with low, intermediate or high rMED score (Figure 1). Increasing rMED
score values were associated with higher adherence to the nutritional recommendations. Interestingly,
whereas the adherence to the nutritional recommendations for added sugar and carbohydrates was
good in all three groups, the adherence to the recommendations for fiber and saturated fat remained
low even in the high rMED score group. In this group, the proportion of adherence was respectively
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31% for saturated fat and 17% for fiber, which is significantly higher than in the low rMED score group,
although still far from optimal.
With regard to the cardiovascular risk factors profile, a high versus low rMED score was
associated with a more favorable plasma lipid profile—i.e., lower LDL cholesterol (101.5 ± 31.2
vs. 105.1 ± 31.9 mg/dL, p = 0.035) and triglycerides (146.7 ± 71.0 vs. 156.2 ± 78.6 mg/dL, p = 0.040),
and higher HDL cholesterol (46.8 ± 12.4 vs. 45.3 ± 11.6 mg/dL, p = 0.032), significantly lower blood
pressure—systolic (133.3 ± 23.7 vs. 135.3 ± 14.9 mmHg, p = 0.045) and diastolic (78.6 ± 8.5 vs.
80.7 ± 8.7 mmHg, p < 0.0001)—lower HbA1c (7.63 ± 0.48 vs. 7.69 ± 0.52%, p = 0.038), lower BMI
(30.0± 4.2 vs. 30.6± 4.5 kg/m2, p = 0.020), and lower C-reactive protein (3.12± 4.8 vs. 3.79± 6.7 mg/L,
p = 0.029) (Table 4). Of note, the proportion of people on lipid- or blood pressure-lowering drugs was
not significantly different across the three groups (Table 4), thus suggesting a significant effect of diet
beyond the effect of drugs.
Finally, we explored the association of the rMED score globally and for the single food groups
with the achievement of treatment targets for plasma lipids, blood pressure, HbA1c, and BMI (Table 5).
The odds of reaching the treatment target for LDL cholesterol increased by 13% per unit increase in
the rMED score for fruit and nuts (OR 1.134; CI 1.006–1.277); for triglycerides, there was a significant
association with fish consumption (OR 1.128; CI 1.003–1.269), and for HDL cholesterol a significant
association was found for fruit and nuts (OR 1.142; CI 1.016–1.283) and alcohol (moderate consumption)
(OR 1.206; CI 1.090–1.335). As for systolic blood pressure, the score for fruit and nuts (OR 1.174;
CI 1.034–1.333), legumes (OR 1.259; CI 1.106–1.433), cereals (OR 1.133; CI 1.001–1.284), fish (OR 1.146;
CI 1.013–1.297) and meat (inverse) (OR 1.170; CI 1.035–1.323) were all significantly associated with
achievement of treatment targets; data for diastolic blood pressure were similar (not shown). The score
for meat (low consumption) (OR 1.141; CI 1.035–1.258), fish (OR 1.109; CI 1.004–1.225), and alcohol
(moderate consumption) (OR 1.183; CI 1.090–1.284) were also significantly associated with likelihood
of a BMI below 30 kg/m2. For HbA1c, a significant association was found for fish (inverse) (OR 0.888;
CI 0.803–0.981) and dairy products (low consumption) (OR 1.154; CI 1.045–1.273).
Table 1. Characteristics of the study participants by rMED score groups.
rMED Score Groups
p-Value
Low (Score 0–6) (n = 834) Intermediate (Score 7–10)(n = 1029)
High (Score 11–18)
(n = 705)
Age (years)
<60 years (%) 316 (37.9) 355 (34.5) 221 (31.3)
0.027≥60 years (%) 518 (62.1) 674 (65.5) 484 (68.7)
Sex
Men (%) 537 (64.4) 601 (58.4) 396 (56.2)
0.002Women (%) 297 (35.6) 428 (41.6) 309 (43.8)
Geographical Area
North (%) 369 (44.2) 349 (33.9) 175 (24.8)
Centre (%) 219 (26.3) 287 (27.9) 171 (24.3) <0.0001
South (%) 246 (29.5) 393 (38.2) 359 (50.9)
Education
Secondary/University (%) 261 (31.3) 326 (31.7) 232 (33.0)
0.607None/Primary (%) 573 (68.7) 703 (68.3) 472 (67.0)
Smoking status 1
Never smoker (%) 388 (46.5) 510 (49.6) 341 (48.4)
Current Smoker (%) 152 (18.2) 182 (17.7) 110 (15.6) 0.376
Former Smoker (%) 294 (35.3) 337 (32.8) 254 (36.0)
Marital status
Married (%) 697 (83.6) 868 (84.3) 615 (87.2)
0.112Single or widowed (%) 137 (16.4) 161 (15.6) 90 (12.8)
Data are expressed as number and percentage. Subjects are classified as “current smokers” if they smoke ≥5
cigarettes/day, and “former smokers” if they had smoked in the past and had stopped smoking for at least 1 year.
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Table 2. Consumption of food groups (expressed as g/1000 kcal/day) by rMED score groups.
rMED Score Groups
Food Item Low (Score 0–6)(n = 834)
Intermediate (Score
7–10) (n = 1029)
High (Score 11–18)
(n = 705) p-Value for Trend
Fruit & Nuts 125.8 ± 79.6 161.2 ± 93.2 200.7 ± 84 * <0.0001
Vegetables 66.7 ± 36.1 96.9 ± 46.2 124 ± 44.6 * <0.0001
Legumes 8.2 ± 7.2 13.5 ± 10.5 19.3 ± 12.1 * <0.0001
Cereals 90.3 ± 35.5 95.8 ± 36.7 95.6 ± 32.6 * 0.033
Fish 16.9 ± 13.1 22.8 ± 16.4 28.9 ± 18.1 * <0.0001
Olive oil 9.4 ± 4.7 13 ± 5.6 16.4 ± 5.6 * <0.0001
Meat 76.4 ± 28.2 68 ± 27.8 58.7 ± 24.5 * <0.0001
Dairy products 24.8 ± 14.5 20.3 ± 12.2 14.8 ± 10.2 * <0.0001
Alcohol 0.27 ± 0.44 0.41 ± 0.50 0.50 ± 0.50 * <0.0001
Data are expressed as mean ± standard deviation; * p < 0.001 vs. low score, post-hoc test adjusted for multiple
comparisons (Bonferroni Test).
Table 3. Energy and nutrient composition of the diet by rMED score groups.
rMED Score Groups
p-Value for Trend
Low (Score 0–6) (n = 834) Intermediate (Score 7–10)(n = 1029)
High (Score 11–18)
(n = 705)
Total Energy (kcal/day) 2093 ± 773 1890 ± 638 1718 ± 561 * <0.0001
Proteins (% TE) 18.6 ± 2.5 18.3 ± 2.6 17.7 ± 2.3 * <0.0001
Animal sources (% TE) 13.4 ± 3 12.55 ± 3.2 11.6 ± 2.8 * <0.0001
Vegetable sources (% TE) 5.2 ± 1.1 5.7 ± 1.1 6.1 ± 1 * <0.0001
Lipids (% TE) 37.0 ± 5.8 36.5 ± 6.3 36.5 ± 5.6 0.166
SFA (% TE) 13.4 ± 2.5 12.1 ± 2.3 10.9 ± 2 * <0.0001
MUFA (% TE) 16.9 ± 3.3 17.9 ± 3.9 19.0 ± 3.7 * <0.0001
PUFA (% TE) 4.3 ± 1.1 4.4 ± 1.2 4.5 ± 1.0 * 0.034
Cholesterol (mg/die) 379 ± 162 325 ± 133 272 ± 111 * <0.0001
Carbohydrates (% TE) 44.3 ± 7.2 45.1 ± 7.6 45.8 ± 6.5 * <0.0001
Added sugars (% TE) 3.0 ± 3.7 2.2 ± 3.0 2.0 ± 2.7 * <0.0001
Fiber (g/1000 kcal/day) 8.8 ± 2.0 10.8 ± 2.3 12.8 ± 2.4 * <0.0001
Glycaemic Index 52.7 ± 3.7 51.8 ± 3.5 51.3 ± 3.2* <0.0001
Glycaemic load 143.4 ± 68.2 113.8 ± 46.8 98.9 ± 37.5 * <0.0001
Alcohol (g/die) 12.9 ± 20.5 10.2 ± 13.5 10.4 ± 12.2 * <0.0001
Calcium (mg) 1007 ± 476 880 ± 370 759 ± 333 * <.0001
Sodium (mg) 2453 ± 1132 2077 ± 938 1758 ± 752 * <0.0001
Potassium (mg) 3045 ± 1087 3045 ± 946 3072 ± 984 0.832
Total Polyphenols (mg) 653 ± 317 674 ± 289 733 ± 280 * <0.0001
Data are expressed as mean ± standard deviation; * p < 0.001 vs. low score, Post-hoc test adjusted for multiple
comparisons (Bonferroni Test). TE: Total Energy; SFA: Saturated fatty acids; MUFA: Monounsaturated fatty acids;
PUFA: Polyunsaturated fatty acids.
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Figure 1. Adherence to the nutritional recommendations for people with diabetes (DNSG [27] and
SID [28]) by rMED score. DNSG: Diabetes and Nutrition Study Group; SID: Italian Diabetes Society;
SFA: Saturated Fatty Acids; Chol: Cholesterol; CHO: Carbohydrates.
Table 4. Cardiovascular risk factors profile by rMED score groups.
rMED Score Groups
p-Value for TrendLow (Score 0–6)
(n = 834)
Intermediate(Score 7–10)
(n = 1029)
High (Score 11–18)
(n = 705)
BMI (kg/m2) 30.6 ± 4.5 30.1 ± 4.4 30.0 ± 4.2 * 0.020
HbA1c (%) 7.69 ± 0.52 7.67 ± 0.49 7.63 ± 0.48 * 0.038
LDL cholesterol (mg/dL) 105.1 ± 31.9 101.8 ± 30.8 101.5 ± 31.2 * 0.035
HDL cholesterol (mg/dL) 45.3 ± 11.6 45.8 ± 11.4 46.8 ± 12.4 * 0.032
Triglycerides (mg/dL) 156.2 ± 78.6 50.2 ± 73.9 46.7 ± 71.0 * 0.040
Systolic blo d pressure (mmHg) 135.3 ± 14.9 133.5 ± 14.4 133.3 23.7 * 0.045
Diastolic blood pressure (mmHg) 80.7 ± 8.7 79.3 ± 8.4 78.6 ± 8.5 * <0.0001
C-reactive protein 1 (mg/L) 3.79 ± 6.7 3.23 ± 4.7 3.12 ± 4.8 * 0.029
People on blood pressure lowering
drugs (%) 73.7 71.9 68.4 0.063
People on lipid low ring drugs (%) 65.1 66. 67.0 0.702
M ± SD or %. * p < 0.05 vs. low score. Post-hoc test adjusted for multiple comparisons (Bonferroni Test). 1 Excluding
subjects with C-reactive protein value >100 mg/L.
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Table 5. Odds ratio (95% CI) for the achievement of treatment target for LDL cholesterol, triglycerides, HDL-cholesterol, systolic blood pressure, BMI, and HbA1c
associated to one-point increase of the total rMED score and of the score for each food item component of the score.
Odd Ratio (95% CI)
LDL-Chol
<100 mg/dL
Triglycerides
<150 mg/dL
HDL-Chol
>40 M or 50 F mg/dL
Systolic BP
<130 mmHg
HbA1c
<7.5%
BMI
<30 kg/m2
Total rMED Score 1.119 (1.002–1.250) * 1.128 (1.036–1.228) * 1.150 (1.006–1.315) * 1.305 (1.100–1.548) * 1.087 (1.001–1.180) * 1.097 (1.005–1.197) *
Mediterranean food item
Fruits and Nuts 1.134 (1.006–1.277) * 1.024 (0.908–1.155) 1.142 (1.016–1.283) * 1.174 (1.034–1.333) * 1.041 (0.941–1.152) 0.997 (0.902–1.102)
Vegetables 0.979 (0.848–1.132) 1.017 (0.879–1.177) 0.948 (0.821–1.094) 1.074 (0.921–1.252) 1.056 (0.928–1.202) 0.901 (0.793–1.024)
Legumes 1.015 (0.898–1.146) 1.004 (0.888–1.136) 1.013 (0.897–1.144) 1.259 (1.106–1.433) * 1.057 (0.954–1.171) 0.981 (0.874–1.010)
Cereals 0.953 (0.848–1.070) 1.009 (0.897–1.135) 0.917 (0.816–1.030) 1.133 (1.001–1.284) * 0.924 (0.834–1.024) 1.049 (0.947–1.161)
Meat and meat products (low intake) 1.051 (0.936–1.180) 1.003 (0.892–1.127) 1.020 (0.909–1.145) 1.170 (1.035–1.323) * 1.082 (0.981–1.194) 1.141 (1.035–1.258) *
Fish 1.073 (0.955–1.205) 1.128 (1.003–1.269) * 0.978 (0.871–1.098) 1.146 (1.013–1.297) * 0.888 (0.803–0.981) * 1.109 (1.004–1.225) *
Dairy products (low intake) 1.036 (0.922–1.165) 0.958 (0.851–1.078) 1.006 (0.895–1.131) 1.044 (0.922–1.182) 1.154 (1.045–1.273) * 1.005 (0.911–1.108)
Olive oil 0.928 (0.806–1.068) 1.053 (0.914–1.214) 0.975 (0.847–1.122) 0.982 (0.845–1.140) 0.974 (0.858–1.107) 1.066 (0.939–1.210)
Moderate alcohol consumption 1.052 (0.951–1.165) 1.075 (0.970–1.191) 1.206 (1.090–1.335) * 1.061 (0.952–1.182) 1.019 (0.939–1.106) 1.183 (1.090–1.284) *
* p < 0.05.
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4. Discussion
Several scores have been developed to evaluate the degree of adherence to the Mediterranean
Diet, but none has been validated so far for the use in people with diabetes, for whom nutritional
therapy and, hence, food choice restrictions and limited consumption of selected food is recommended.
The reason we selected the rMED score for this study [26] is because it excludes sweetened beverages
and potatoes which are foods restricted in people with diabetes.
Although not specifically validated for people with diabetes, the rMED score efficiently identified
three groups with substantially different eating habits. The study results show that in real-life clinical
practice, the dietary habits of people with type 2 diabetes vary significantly with gender, age, and area
of residence. In particular, females, older people, and residents of the southern regions tend to adhere
more to a Mediterranean eating pattern.
The habitual diet of people with a high rMED score, as compared to that of people with a low
score, was characterized by a lower energy intake, a lower intake of saturated fat and cholesterol,
a higher intake of fish, vegetable proteins and fiber; glycemic index and glycemic load were also
significantly lower, as was the intake of sodium and calcium, whereas the intake total polyphenols
was significantly higher. On the overall, this group had a significantly less atherogenic and less
proinflammatory diet. Nevertheless, even in the group with the highest score, the intake of fiber and
saturated fat remained respectively lower and higher than recommended by the European and Italian
nutritional guidelines for people with diabetes [27,28].
A low consumption of fiber and a relatively high intake of saturated fat have been reported
by other studies in type 1 and type 2 diabetes [2–4] and most likely reflect the wider problem of
a progressive shifting towards more western dietary models in all cultures, including countries
with strong Mediterranean roots like Italy [29,30]. This notwithstanding, a high rMED score is
associated with a more favorable cardiovascular risk factors profile, lower BMI, lower HbA1c, and
lower subclinical inflammation. The magnitude of the differences between the high and low rMED
score group may seem trivial, but if translated at the population level, may considerably impact on the
absolute cardiovascular risk of the study population. Based on prior observational and intervention
studies exploring the impact of the modification of major cardiovascular risk factors on the absolute
cardiovascular risk [31–35], it can be estimated that combining the differences between the high and
low rMED score groups in LDL cholesterol, triglycerides, HDL cholesterol, blood pressure, and HbA1c
could result in a 21% reduction of the estimated absolute cardiovascular risk. Thus, emphasizing that
the individual effects of the Mediterranean diet are small but taken as a whole the effects are large.
To our knowledge, this is one of the very few studies exploring the impact of a Mediterranean-like
dietary pattern on glucose control and major cardiovascular risk factors in people with type 2 diabetes
in real-life conditions. Most prior evidence on the beneficial effects of a Mediterranean diet model in
people with diabetes comes from intervention trials, often of short duration, some of which have used
food supplements [14,15,36]. The results of this study are in line with observational studies conducted
in people without diabetes, and with a recent observational study conducted in a community-based
sample of people with type 2 diabetes showing a significant reduction of all cause and cardiovascular
deaths in patients who adhered most to the Mediterranean diet [37]. However, the lack of data on
intermediate outcomes in this study does not allow comparisons with our findings. In addition, there is
no standard definition for the Mediterranean diet, and adherence scores are based on population
specific cut-off values for food consumption; this makes them poorly reproducible when utilized in
different population groups, and further limits comparison between different studies.
We also explored the relation between scores of each individual food group component of the
Mediterranean diet and the achievement of treatment targets for individual risk factors. Based on
these analyses, a differential effect of single food groups was observed with regard to different risk
factors (i.e., increasing the scores for fruit and vegetables significantly improved the probability of
reaching the treatment target for LDL cholesterol; increasing the consumption of fish significantly
improve the likelihood of reaching the target for triglycerides; the scores for legumes and vegetables
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were the main drivers for the achievement of treatment targets for blood pressure, etc.). All together,
these data point to the conclusion that the beneficial health effects of the Mediterranean diet are largely
due to the overall diet rather than being driven by single components, as different food items target
different risk factors.
The major study strengths rely on the large sample size, the selection of a study population
representative of real-life clinical practice, the standardized collection of nutritional and clinical data
and the centralized biochemical measurements. Among the study limitations, we acknowledge
the cross-sectional design and the use of intermediate endpoints. In addition, the dietary data
were collected only once and could be prone to recall bias and seasonal variation, which might,
however, bias the findings towards null, thus leading to the underestimation of the effect size. Finally,
the extensive use of hypolipidemic and antihypertensive drugs could have partly offset the quantitative
effect of nutritional factors. In this regard, the appreciation of the impact of dietary adherence in the
face of pharmacological treatment was even more relevant.
5. Conclusions
In conclusion, a dietary pattern mimicking the Mediterranean model in people with type 2 diabetes
is associated with more favorable cardiovascular risk factors profile, better glucose control and lower
BMI and it is therefore a valid and sustainable nutritional strategy for people with diabetes in real-life
clinical practice. However, a high rMED score in this population does not guarantee an ideal adherence
to the nutritional recommendations for the management of diabetes, in fact, the intake of saturated fat
and fiber in the highest rMED score group remain respectively higher and lower than recommended.
These findings together with available evidence from other observational and intervention studies
emphasize the need to reinforce the importance of higher fiber, low glycemic index foods such as
legumes, fruit and vegetables, wholegrain cereals, and the substitution of monounsaturated for
saturated fat sources, in energy balanced conditions, in people with diabetes.
Large-scale primary prevention trials focused on dietary patterns and cardiovascular disease risk
in people with diabetes are unlikely to be undertaken; hence, observational findings such as these
represent an important basis for dietary recommendations, government programs, and negotiations
with industry to help people make healthy food choices.
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